Importance of Cytoreductive TherapyVideo Categories: Polycythemia Vera http://cdn.personalizedmedonc.com/P_Vera/F01_Laura_Michaelis_PMO_Polycythemia_Approaches_LynxMp4_1.mp4 Laura C. Michaelis, MD, Medical College of Wisconsin describes why cytoreductive therapy is important to discuss with patients with polycthemia vera.
Supported through funding from Incyte
Dr Andrey Antov provides a useful metaphor to explain how genetic testing and genomic testing differ from one another and the purpose behind each type of testing.
New Clinical Trial Data in Advanced Melanoma Presented at ASCO 2018: How Will it Change How You Practice?
Dr Sanjiv Agarwala talks about exciting new results presented at ASCO 2018 in melanoma, including the durability of anti–PD-1 therapy in providing 40% overall survival at 5 years, updates on adjuvant therapy showing superiority of anti–PD-1 over anti–CTLA-4, and new results in combining immunotherapies.